The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has asked Ranbaxy to recall three batches of Pravastatin as the company failed to update safety warnings on its information leaflets.
Ranbaxy has been asked to recall Pravastatin 10mg tablets batch 2131768 and Pravastatin 40mg tablets batches 2117477 and 2129684.
The agency said Ranbaxy failed to update the patient information leaflets to include approved safety warnings, some of which were mandatory and initiated by the European Medicines Agency.
Pharmacists have been asked to quarantine all remaining stock of these batches and return it to the wholesaler from which it was purchased.
In addition, primary care trusts are asked to bring the notice to the attention of community pharmacists, general practitioners, dental practitioners and extended formulary nurse prescribers.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData